BNP Paribas Financial Markets’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-23,663
| Closed | -$460K | – | 4552 |
|
|
2018
Q1 | $460K | Sell |
23,663
-15,723
| -40% | -$309K | ﹤0.01% | 2266 |
|
|
2017
Q4 | $656K | Buy |
39,386
+153
| +0.4% | +$2.8K | ﹤0.01% | 2286 |
|
|
2017
Q3 | $796K | Buy |
39,233
+15,735
| +67% | +$301K | ﹤0.01% | 1709 |
|
|
2017
Q2 | $378K | Buy |
23,498
+8,469
| +56% | +$125K | ﹤0.01% | 2075 |
|
|
2017
Q1 | $190K | Buy |
15,029
+1,588
| +12% | +$19.2K | ﹤0.01% | 2236 |
|
|
2016
Q4 | $178K | Buy |
13,441
+2,099
| +19% | +$35.9K | ﹤0.01% | 2270 |
|
|
2016
Q3 | $269K | Sell |
11,342
-22,866
| -67% | -$615K | ﹤0.01% | 1586 |
|
|
2016
Q2 | $986K | Buy |
34,208
+10,968
| +47% | +$357K | ﹤0.01% | 1175 |
|
|
2016
Q1 | $744K | Buy |
23,240
+9,564
| +70% | +$336K | ﹤0.01% | 1093 |
|
|
2015
Q4 | $585K | Sell |
13,676
-1,136
| -8% | -$45.4K | ﹤0.01% | 1293 |
|
|
2015
Q3 | $522K | Buy |
14,812
+8,847
| +148% | +$399K | ﹤0.01% | 1333 |
|
|
2015
Q2 | $274K | Buy |
5,965
+573
| +11% | +$27.2K | ﹤0.01% | 1577 |
|
|
2015
Q1 | $253K | Buy |
5,392
+3,939
| +271% | +$157K | ﹤0.01% | 1495 |
|
|
2014
Q4 | $46K | Sell |
1,453
-7,762
| -84% | -$227K | ﹤0.01% | 1703 |
|
|
2014
Q3 | $218K | Buy |
9,215
+4,878
| +112% | +$125K | ﹤0.01% | 1822 |
|
|
2014
Q2 | $130K | Buy |
4,337
+1,123
| +35% | +$30.3K | ﹤0.01% | 1938 |
|
|
2014
Q1 | $84K | Buy |
3,214
+2,327
| +262% | +$58.2K | ﹤0.01% | 2026 |
|
|
2013
Q4 | $22.3K | Sell |
887
-17,767
| -95% | -$396K | ﹤0.01% | 2202 |
|
|
2013
Q3 | $382K | Sell |
18,654
-5,450
| -23% | -$113K | ﹤0.01% | 1745 |
|
|
2013
Q2 | $481K | Buy |
+24,104
| New | +$428K | ﹤0.01% | 1591 |
|
BNP Paribas Financial Markets's IPXL Position: Q2 2018 in Review
BNP Paribas Financial Markets sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 23,663 shares — an estimated $460K sold.
BNP Paribas Financial Markets first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $986K in Q2 2016. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- BNP Paribas Financial Markets reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- BNP Paribas Financial Markets sold 23,663 Impax Laboratories, Inc. shares in Q2 2018, an estimated $460K.
- BNP Paribas Financial Markets first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- BNP Paribas Financial Markets's Impax Laboratories, Inc. position peaked at $986K in Q2 2016.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2018, filed 25 Jul 2018.